Coinciding with National Breast Cancer Awareness Month, Mammography Reporting System (MRS) Partners with DrFirst to Provide Its Clients Award-Winning E-Prescribing

Share Article

Mammography Reporting System, the most widely used tracking & reporting system in the world for all breast-related procedures, including mammography, MRI, and ultrasound, announced it has partnered with DrFirst to provide comprehensive e-prescribing and medication management functionality with the MRS7 Reporting software as a part of the MRS initiative to achieve Meaningful Use certification as an ambulatory EMR. The partnership brings the safety and efficiency benefits of DrFirst’s Gold Certified Rcopia e-prescribing to MRS7 Reporting software

Partnering with DrFirst in this integration extends the capabilities of thousands of MRS users to achieve early compliance with the Meaningful Use guidelines established by HHS, said MRS President Mark P. Morris.

Mammography Reporting System, the most widely used tracking & reporting system in the world for all breast-related procedures, including mammography, MRI, and ultrasound, announced it has partnered with DrFirst to provide comprehensive e-prescribing and medication management functionality with the MRS7 Reporting software as a part of the MRS initiative to achieve Meaningful Use certification as an ambulatory EMR. The partnership brings the safety and efficiency benefits of DrFirst’s Gold Certified Rcopia e-prescribing to MRS7 Reporting software.

“Partnering with DrFirst in this integration extends the capabilities of thousands of MRS users to achieve early compliance with the Meaningful Use guidelines established by HHS,” said MRS President Mark P. Morris. “Although radiologists have been investing heavily in IT for years, significant financial incentives from the government will help them remain on the leading edge of new IT capabilities. E-prescribing is a Meaningful Use requirement, and we are happy to be able to offer DrFirst’s best-of-breed solution.”

“As indicated in our name, DrFirst’s goal is always to put the doctor first. Integrating with MRS is a wonderful example of a partner sharing our vision,” said DrFirst President G. Cameron Deemer. “The announcement of the DrFirst-MRS partnership is especially timely with October being National Breast Cancer Awareness Month. This integration will allow MRS clients and their patients to benefit from enhanced patient safety realized when e-prescribing, to participate in current government incentive programs including ARRA/HITECH,PQRI and MIPPA, and to avoid future reductions in reimbursement.”

With the integration of DrFirst’s Rcopia e-prescribing technology, MRS users will be able to easily and securely submit electronic prescriptions to any retail or mail-order pharmacy while accessing comprehensive clinical information for each patient. Accessible patient information includes drug and allergy interactions, complete prescribing histories and formulary information. Doctors and staff will be able to easily access the Surescripts-certified functionality from within the MRS system and all resulting prescribing data is instantly captured within the application.

About DrFirst, Inc.

Founded in 2000, DrFirst is the nation's leading e-prescribing solution provider to physician practices, major health plans, health systems, hospitals, and EHR companies. Through its Open Borders Program, DrFirst solutions are widely integrated with over 200 EHR systems. DrFirst is a Surescripts Gold Certified solution provider and aggregator, offering its award-winning Rcopia electronic prescription management system as both a standalone application and as a technology platform. DrFirst utilizes the Surescripts network for pharmacy connectivity, health plan information, and patient medication history. DrFirst is the first organization in the country certified to meet Drug Enforcement Administration (DEA) requirements for e-prescribing of controlled substances (EPCS). The DrFirst EPCS Gold™ e-prescribing solution is a platform available nationally to HIT vendors for prescriber identity proofing and electronic transmission of controlled drugs. Certain DrFirst solutions can qualify users for government incentive programs such as MIPPA, PQRI/PQRS, and Meaningful Use of EHR For more information contact DrFirst at (888)-DRFIRST or visit drfirst.com. Stay up to date with DrFirst news at blog.drfirst.com or follow DrFirst on Twitter and Facebook at twitter.com/drfirst and facebook.com/DrFirstInc.

About Mammography Reporting System (MRS)

Mammography Reporting System (MRS) is the most widely used tracking & reporting system in the world for all breast-related procedures. MRS is installed worldwide in thousands of facilities, from IDN’s with over 50 hospitals and clinics, to small imaging facilities with one or two radiologists. The MRS system tracks breast procedure patients, collects their data, and generates reports and patient lay letters while providing breast cancer risk calculations to individualize breast health management strategies for all women by their medical caregivers. By year end 2011 MRS will achieve full ambulatory EHR certification. MRS is based on the fundamental idea that information is paramount in the eyes of both the clinician and the patient. For more information, visit http://www.mrsys.com or call 800-253-4827

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rod Neaveill
DrFirst
(301) 231-9510
Email >
Visit website